Search Results for

Showing 11 - 20 of 63 results
  1. Board of Trustees

    Board of Trustees The Board of Trustees is comprised of elected members from ARVO's 13 Scientific Sections along with elected and trustee-appointed officers. The president and vice president(s) are elected from within the Board each year. The executive vice president is elected by the general membership to a five-year term and is a voting member of the Board of Trustees. The ARVO executive director serves as an ex officio member of the Board. For more information on Board of Trustee duties,

  2. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  3. Scientific Sections

    Scientific Sections ARVO is organized into 13 Scientific Sections, which are described below. Members must select one section with which their research interests most closely identify. Each section is represented on the Board of Trustees and the Annual Meeting Program Committee. Anatomy and Pathology/Oncology (AP)   Anatomy Sub-section includes descriptive or experimental studies about the gross and surgical anatomy, ultrastructure, organization, and development of the tissues, visual pathway

  4. OCT paper

    A peer-reviewed publication finds that vision research pays for itself

  5. OCT paper

    A peer-reviewed publication finds that vision research pays for itself

  6. CME/CE

    Obtaining credits for attending ARVO's CME-certified activities.